Quarterly report pursuant to Section 13 or 15(d)

Composition of Certain Financial Statement Captions - Changes in Goodwill (Details)

v3.8.0.1
Composition of Certain Financial Statement Captions - Changes in Goodwill (Details)
$ in Thousands
9 Months Ended
Sep. 30, 2017
USD ($)
Goodwill [Roll Forward]  
Beginning balance $ 704,603
Foreign exchange and other 10,970
Ending balance 715,573
BioReference  
Goodwill [Roll Forward]  
Ending balance 401,800
Pharmaceutical | CURNA  
Goodwill [Roll Forward]  
Beginning balance 4,827
Foreign exchange and other 0
Ending balance 4,827
Pharmaceutical | EirGen  
Goodwill [Roll Forward]  
Beginning balance 78,358
Foreign exchange and other 9,639
Ending balance 87,997
Pharmaceutical | FineTech  
Goodwill [Roll Forward]  
Beginning balance 11,698
Foreign exchange and other 0
Ending balance 11,698
Pharmaceutical | OPKO Chile  
Goodwill [Roll Forward]  
Beginning balance 4,785
Foreign exchange and other 217
Ending balance 5,002
Pharmaceutical | OPKO Biologics  
Goodwill [Roll Forward]  
Beginning balance 139,784
Foreign exchange and other 0
Ending balance 139,784
Pharmaceutical | OPKO Health Europe  
Goodwill [Roll Forward]  
Beginning balance 6,936
Foreign exchange and other 853
Ending balance 7,789
Pharmaceutical | OPKO Renal  
Goodwill [Roll Forward]  
Beginning balance 2,069
Foreign exchange and other 0
Ending balance 2,069
Pharmaceutical | Transition Therapeutics  
Goodwill [Roll Forward]  
Beginning balance 3,360
Foreign exchange and other 261
Ending balance 3,621
Diagnostics | BioReference  
Goodwill [Roll Forward]  
Beginning balance 401,821
Foreign exchange and other 0
Ending balance 401,821
Diagnostics | OPKO Diagnostics  
Goodwill [Roll Forward]  
Beginning balance 17,977
Foreign exchange and other 0
Ending balance 17,977
Diagnostics | OPKO Lab  
Goodwill [Roll Forward]  
Beginning balance 32,988
Foreign exchange and other 0
Ending balance $ 32,988